ARG1 and neoplasm: In a tumor setting, an ARG1-induced depletion of L-arginine impairs T cell receptor (TCR) signaling through the downregulation of TCR ζ chain expression, induces T cell cycle arrest, limits T cell differentiation, and reduces cytokine production (6).